Files
2026-07-06 17:27:20 -04:00

72 lines
3.1 KiB
Markdown
Raw Permalink Blame History

This file contains ambiguous Unicode characters
This file contains Unicode characters that might be confused with other characters. If you think that this is intentional, you can safely ignore this warning. Use the Escape button to reveal them.
---
type: "Bill"
title: "Drugs and Devices - Electronic Prescriptions - Controlled Dangerous Substances"
description: "Drugs and Devices - Electronic Prescriptions - Controlled Dangerous Substances"
jurisdiction: "us/states/md"
legislature: "Maryland General Assembly"
session: "2020"
identifier: "SB 166"
citation: "Maryland SB 166 (2020)"
classification: ["bill"]
subjects: []
status: "enacted"
primary_sponsors: ["Kelley"]
version_count: 3
action_count: 14
vote_count: 2
first_action: "2020-01-13"
last_action: "2020-05-08"
source: "openstates"
source_identifier: "ocd-bill/f1c39702-ad7d-4788-85bd-09ce2e5ecf33"
source_url: "http://mgaleg.maryland.gov/mgawebsite/Legislation/Details/sb0166?ys=2020RS&search=True"
source_hash: "9a89ab6a783e7e5483e8e4f6d57772351959a0f32f1e3b0fcd32121c680c3927"
vintage: "2026-07-01"
source_snapshot: "https://data.openstates.org/daily/2026-07-01/public.pgdump"
retrieved_at: "2026-07-06"
confidence: "reported"
tags: ["legislation", "bill", "us-md"]
---
# Maryland SB 166 (2020) — Drugs and Devices - Electronic Prescriptions - Controlled Dangerous Substances
## Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
1. **Chapter - Drugs and Devices - Electronic Prescriptions - Controlled Dangerous Substances** (committee substitute) — [source](http://mgaleg.maryland.gov/2020RS/Chapters_noln/CH_229_sb0166t.pdf)
2. **First - Drugs and Devices - Electronic Prescriptions - Controlled Dangerous Substances** (committee substitute) — [source](http://mgaleg.maryland.gov/2020RS/bills/sb/sb0166f.pdf)
3. **Third - Drugs and Devices - Electronic Prescriptions - Controlled Dangerous Substances** (committee substitute) — [source](http://mgaleg.maryland.gov/2020RS/bills/sb/sb0166t.pdf)
## Votes
- On Third Reading — **470** (pass) · upper
- On Third Reading — **1320** (pass) · lower
## Sponsors
- Kelley — primary (person)
## Timeline
The legislative action history — every referral, reading, and vote.
- **2020-01-13** First Reading Finance `referral-committee`
- **2020-01-15** Hearing 2/06 at 1:00 p.m.
- **2020-02-03** Hearing canceled
- **2020-02-03** Hearing 2/20 at 1:00 p.m.
- **2020-03-06** Favorable with Amendments Report by Finance `committee-passage-favorable`
- **2020-03-09** Favorable with Amendments { `committee-passage-favorable`
- **2020-03-09** Second Reading Passed with Amendments
- **2020-03-11** Third Reading Passed `passage`
- **2020-03-12** Referred Health and Government Operations `referral-committee`
- **2020-03-14** Favorable Report by Health and Government Operations `committee-passage-favorable`
- **2020-03-14** Favorable Adopted Second Reading Passed `committee-passage-favorable`
- **2020-03-16** Third Reading Passed `passage`
- **2020-03-18** Returned Passed
- **2020-05-08** Enacted under Article II, Section 17(c) of the Maryland Constitution - Chapter 229 `became-law`
## Source
OpenStates / OpenCivicData bulk snapshot [2026-07-01](https://data.openstates.org/daily/2026-07-01/public.pgdump); origin `ocd-bill/f1c39702-ad7d-4788-85bd-09ce2e5ecf33`. Confidence: reported (aggregated from official Maryland legislature records).